Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP758337.RAYhEDpGgzk26a8tF2dBE0on3C5dW40aAsJU_kzNYLZy0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP758337.RAYhEDpGgzk26a8tF2dBE0on3C5dW40aAsJU_kzNYLZy0130_assertion type Assertion NP758337.RAYhEDpGgzk26a8tF2dBE0on3C5dW40aAsJU_kzNYLZy0130_head.
- NP758337.RAYhEDpGgzk26a8tF2dBE0on3C5dW40aAsJU_kzNYLZy0130_assertion wasGeneratedBy ECO_0000203 NP758337.RAYhEDpGgzk26a8tF2dBE0on3C5dW40aAsJU_kzNYLZy0130_provenance.
- NP758337.RAYhEDpGgzk26a8tF2dBE0on3C5dW40aAsJU_kzNYLZy0130_assertion wasDerivedFrom befree-20140225 NP758337.RAYhEDpGgzk26a8tF2dBE0on3C5dW40aAsJU_kzNYLZy0130_provenance.
- NP758337.RAYhEDpGgzk26a8tF2dBE0on3C5dW40aAsJU_kzNYLZy0130_assertion SIO_000772 15576429 NP758337.RAYhEDpGgzk26a8tF2dBE0on3C5dW40aAsJU_kzNYLZy0130_provenance.
- NP758337.RAYhEDpGgzk26a8tF2dBE0on3C5dW40aAsJU_kzNYLZy0130_assertion evidence source_evidence_literature NP758337.RAYhEDpGgzk26a8tF2dBE0on3C5dW40aAsJU_kzNYLZy0130_provenance.
- NP758337.RAYhEDpGgzk26a8tF2dBE0on3C5dW40aAsJU_kzNYLZy0130_assertion description "[Apolipoprotein C-III (apo C-III) is a marker of cardiovascular disease risk associated with triglyceride (TG)-rich lipoproteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP758337.RAYhEDpGgzk26a8tF2dBE0on3C5dW40aAsJU_kzNYLZy0130_provenance.